Nuvalent (NUVL) Change in Acquisitions & Divestments (2022 - 2026)

Nuvalent (NUVL) reported Change in Acquisitions & Divestments of $181.5 million for Q1 2026, down 40.0% on a YoY basis from $302.6 million in Q1 2025, and up 11.31% quarter-over-quarter from $163.1 million in Q4 2025.

Nuvalent (NUVL) Change in Acquisitions & Divestments (2022 - 2026) Analysis & Trends

Nuvalent has reported Change in Acquisitions & Divestments for 5 years, with the latest figure at $181.5 million in Q1 2026.

  • For the quarter ending Q1 2026, Change in Acquisitions & Divestments fell 40.0% year-over-year to $181.5 million; the trailing twelve-month figure through Mar 2026 stood at $812.6 million (up 19.9% YoY), and the FY2025 full-year result was $933.7 million, up 106.82% from the prior year.
  • Change in Acquisitions & Divestments for Q1 2026 stood at $181.5 million, up from $163.1 million in the prior quarter.
  • The five-year high for Change in Acquisitions & Divestments was $302.6 million in Q1 2025, with the low at $27.0 million in Q1 2022.
  • Historically, Change in Acquisitions & Divestments has averaged $122.6 million across 5 years, with a median of $105.0 million in 2024.
  • Annual changes were most pronounced in 2025 — Change in Acquisitions & Divestments soared 296.85% — and 2026, when it slumped 40.0%.
  • Nuvalent's Change in Acquisitions & Divestments stood at $97.2 million in 2022, then climbed by 13.62% to $110.5 million in 2023, then increased by 28.96% to $142.4 million in 2024, then increased by 14.5% to $163.1 million in 2025, then rose by 11.31% to $181.5 million in 2026.
  • The last three Change in Acquisitions & Divestments figures came in at $181.5 million (Q1 2026), $163.1 million (Q4 2025), and $232.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn -
7 Psyence Biomedical 227.32 Bn 227.31 Bn -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn
9 Abivax 91.71 Bn 91.71 Bn -
10 Nuvalent 9.70 Bn 9.70 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 181.55 Mn
Mar 31, 2026 181.55 Mn
Dec 31, 2025 163.10 Mn
Dec 31, 2025 163.10 Mn
Sep 30, 2025 232.44 Mn
Sep 30, 2025 232.44 Mn
Jun 30, 2025 235.55 Mn
Jun 30, 2025 235.55 Mn
Mar 31, 2025 302.59 Mn
Mar 31, 2025 302.59 Mn
Dec 31, 2024 142.45 Mn
Dec 31, 2024 142.45 Mn
Sep 30, 2024 127.71 Mn
Sep 30, 2024 127.71 Mn
Jun 30, 2024 105.04 Mn
Jun 30, 2024 105.04 Mn
Mar 31, 2024 76.25 Mn
Mar 31, 2024 76.25 Mn
Dec 31, 2023 110.46 Mn
Dec 31, 2023 110.46 Mn